HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
Clinical trial NCT06708663 · RECRUITING
Trial details
- NCT number
- NCT06708663
- Sponsor
- Hangzhou Hanx Biopharmaceuticals, Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-17
- Primary completion
- 2027-12-31
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.